In addition, our results have indicated that thrombolytic therapy could affect the predictive value of MMP-9/BDNF in AIS, partly due to the fact that thrombolysis therapy may affect the expression of MMP-9 (Saleem et al., 2021). The gene discussed is BDNF; the disease is androgen insensitivity syndrome.